Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform

The detection of somatic mutations in primary tumors is critical for the understanding of cancer evolution and targeting therapy. Multiple technologies have been developed to enable the detection of such mutations. | Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations validated by the QIAGEN Therascreen PCR kit and alternative NGS platform

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN